Amerant Bancorp (AMTB) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Reported a net loss of $48.2 million for Q3 2024, or $1.43 per diluted share, primarily due to a $68.5 million pre-tax loss from investment portfolio repositioning and higher noninterest expenses.
Completed a $165 million public offering, raising $155.8 million in net proceeds to support organic growth and balance sheet optimization.
Achieved strong organic loan and deposit growth, with total assets reaching $10.4 billion, up $634.2 million from Q2 2024.
Initiated the sale of Houston banking operations, with $553.9 million in loans and $590.7 million in deposits classified as held for sale; transaction expected to close in Q4 2024.
Announced expansion initiatives in Florida, including new banking centers and organizational changes to enhance focus on international banking.
Financial highlights
Net interest income rose to $81.0 million, up $1.6 million from Q2 2024; net interest margin declined to 3.49% from 3.56%.
Non-interest income was negative $47.7 million due to securities repositioning losses; excluding non-routine items, it was $20.8 million.
Non-interest expense increased to $76.2 million, including $6 million in OREO valuation expense and higher professional fees and salaries.
Provision for credit losses was $19.0 million, slightly down from $19.2 million in Q2 2024.
Total assets were $10.4 billion, total gross loans $7.56 billion, and total deposits $8.11 billion as of September 30, 2024.
Outlook and guidance
CET1 ratio expected to be approximately 11.20% after closing the Houston transaction and to remain above 11% in 2025, supported by projected earnings.
Management expects the capital raise and portfolio repositioning to complete a multi-year transformation, supporting future organic growth and strategic goals.
Anticipates significant reduction in both special mention and non-performing loans in Q4 2024.
Core non-interest income projected at $17.5-$18 million for Q4; operating expenses expected to remain around $68.5 million.
Provision for credit losses anticipated at $8.8-$9 million in Q4; targeting 60% efficiency ratio, 1% ROA, and 12% ROE by H2 2025.
Latest events from Amerant Bancorp
- Q2 net income fell to $5.0M as credit costs and Houston sale charges increased.AMTB
Q2 20242 Feb 2026 - Q4 earnings fell on higher expenses and credit issues, but capital and noninterest income improved.AMTB
Q4 20251 Feb 2026 - Q4 2024 profit rebound with strong loan growth, margin gains, and focus on 2025 expansion.AMTB
Q4 20249 Jan 2026 - Q1 2025 net income was $12M, with strong deposits, efficiency, and higher credit provisions.AMTB
Q1 202523 Dec 2025 - Net income fell to $14.8M on higher provisions, but NIM and core deposits improved.AMTB
Q3 202514 Dec 2025 - Shareholders will vote on directors, executive pay, and auditor, with strong governance and ESG focus.AMTB
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor set for May 7, 2025.AMTB
Proxy Filing1 Dec 2025 - Net income rose to $23.0M in Q2 2025 on higher NII, improved asset quality, and strong deposits.AMTB
Q2 202516 Nov 2025